What is the current price for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

The leading outcome "Yes" is currently trading at 64.0% probability.

How many markets are available for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

There are 6 markets available for this event on Kalshi.

What is the trading volume for "When will Intellia Therapeutics submit a BLA for Lonvo-z?"?

Trading volume data is not currently available.

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Name: When will Intellia Therapeutics submit a BLA for Lonvo-z?
Start: 2026-04-19T06:25:51.248Z
End: 2026-05-19T06:25:51.248Z

Market Price Graph

6 markets tracked

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

kalshi

No data available

All Markets(6)

Market	Price
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)	69%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)	64%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)	60%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)	57%
When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)	48%

Markets (6)

Sort

KALSHITech

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before April 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before 2027)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Jan 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before December)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Dec 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before November)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before October)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Oct 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.

When will Intellia Therapeutics, Inc. submit a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA? (before September)

If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Sep 1, 2026, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.